Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report
- PMID: 26523170
- PMCID: PMC4607982
- DOI: 10.11604/pamj.2015.21.228.7525
Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report
Abstract
We report a case of a 62 year-old patient who developed Palmar-plantar erythrodysesthesia upon receiving four cycles of capacitabine-based chemotherapy. She was on post surgical adjuvant treatment for invasive well differentiated adenocarcinoma of the colon. The clinical and therapeutic aspects of this chemotherapeutic adverse effect are discussed.
Keywords: Kenya; Palmar-plantar erythrodysesthesia; capecitabine.
Figures
References
-
- Saif MW. Capecitabine and hand-foot syndrome. Expert Opin Drug Saf. 2011;10(2):p159–69. - PubMed
-
- Webster-Gandy JD, How C, Harrold K. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs. 2007;11(3):p238–46. - PubMed
-
- Scheithauer W, Blum J. Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine. Oncology (Williston Park) 2004 Aug;18(9):1161–8. 1173. - PubMed
-
- Lin E, Morris JS, Ayers GD. Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology (Williston Park) 2002;16(12 Suppl No 14):p31–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources